Why the study?
Does intravenous high-dose immunoglobulin G improve cardiac function in an adult patient with fulminant myocarditis requiring mechanical circulatory support?
Does intravenous high-dose immunoglobulin G improve cardiac function in an adult patient with fulminant myocarditis requiring mechanical circulatory support?
High-dose intravenous immunoglobulin may serve as a potential adjunctive therapy for fulminant myocarditis by improving cardiac function and suppressing inflammatory mediators.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for IVIG in fulminant myocarditis on MCS; controlled trials needed before any practice change.
The cardiac function of an adult patient with fulminant myocarditis requiring a mechanical circulatory support was improved, along with the suppressed release of inflammatory mediators, after intravenous infusion with high-dose immunoglobulin. This therapy may have immunomodulatory effects and serve as a potential adjunctive therapy for patients with fulminant myocarditis.
No takes yet. Share an insight, caveat, or question.
Takeda et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: